Lys117Arg mutation", "sentences": [], "annotations": [], "relations": []}, {"offset": 38857, "infons": {"fpage": "5705", "pub-id_pmid": "19001320", "section_type": "REF", "source": "J Clin Oncol", "type": "ref", "volume": "26", "year": "2008"}, "text": "Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 38957, "infons": {"fpage": "928", "pub-id_pmid": "16969076", "section_type": "REF", "source": "Cancer Biol Ther", "type": "ref", "volume": "5", "year": "2006"}, "text": "Recurrent KRAS codon 146 mutations in human colorectal cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 39019, "infons": {"fpage": "425", "pub-id_pmid": "10989276", "section_type": "REF", "source": "Cell Signal", "type": "ref", "volume": "12", "year": "2000"}, "text": "The importance of being K-Ras", "sentences": [], "annotations": [], "relations": []}, {"offset": 39049, "infons": {"fpage": "4830", "pub-id_pmid": "18676755", "section_type": "REF", "source": "Clin Cancer Res", "type": "ref", "volume": "14", "year": "2008"}, "text": "K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy", "sentences": [], "annotations": [], "relations": []}, {"offset": 39162, "infons": {"fpage": "184", "pub-id_pmid": "18621636", "section_type": "REF", "source": "Clin Colorectal Cancer", "type": "ref", "volume": "7", "year": "2008"}, "text": "Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab alone", "sentences": [], "annotations": [], "relations": []}, {"offset": 39297, "infons": {"fpage": "299", "pub-id_pmid": "18925961", "section_type": "REF", "source": "BMC Cancer", "type": "ref", "volume": "8", "year": "2008"}, "text": "Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes", "sentences": [], "annotations": [], "relations": []}, {"offset": 39394, "infons": {"fpage": "72", "pub-id_pmid": "16010679", "section_type": "REF", "source": "Am J Med Genet C Semin Med Genet", "type": "ref", "volume": "137C", "year": "2005"}, "text": "Tumor predisposition in Costello syndrome", "sentences": [], "annotations": [], "relations": []}, {"offset": 39436, "infons": {"fpage": "2409", "pub-id_pmid": "2181436", "section_type": "REF", "source": "Proc Natl Acad Sci USA", "type": "ref", "volume": "87", "year": "1990"}, "text": "Hamster cell line suitable for transfection assay of transforming genes", "sentences": [], "annotations": [], "relations": []}, {"offset": 39508, "infons": {"fpage": "1757", "pub-id_pmid": "18946061", "section_type": "REF", "source": "N Engl J Med", "type": "ref", "volume": "359", "year": "2008"}, "text": "K-ras mutations and benefit from cetuximab in advanced colorectal cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 39581, "infons": {"fpage": "253", "pub-id_pmid": "18330678", "section_type": "REF", "source": "Cancer Metastasis Rev", "type": "ref", "volume": "27", "year": "2008"}, "text": "Dual-specificity MAP kinase phosphatases (MKPs) and cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 39640, "infons": {"fpage": "3230", "pub-id_pmid": "17664471", "section_type": "REF", "source": "J Clin Oncol", "type": "ref", "volume": "25", "year": "2007"}, "text": "Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab", "sentences": [], "annotations": [], "relations": []}, {"offset": 39796, "infons": {"fpage": "201", "pub-id_pmid": "10464646", "section_type": "REF", "source": "Genet Test", "type": "ref", "volume": "1", "year": "1997"}, "text": "Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system", "sentences": [], "annotations": [], "relations": []}, {"offset": 39884, "infons": {"fpage": "4656", "pub-id_pmid": "12907646", "section_type": "REF", "source": "Cancer Res", "type": "ref", "volume": "63", "year": "2003"}, "text": "Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas", "sentences": [], "annotations": [], "relations": []}, {"offset": 40000, "infons": {"fpage": "3992", "pub-id_pmid": "16618717", "section_type": "REF", "source": "Cancer Res", "type": "ref", "volume": "66", "year": "2006"}, "text": "KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 40089, "infons": {"fpage": "715", "pub-id_pmid": "19603018", "section_type": "REF", "source": "Br J Cancer", "type": "ref", "volume": "101", "year": "2009"}, "text": "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in 